WELLS FARGO & COMPANY/MN - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$858,610
-25.6%
282,438
-19.5%
0.00%
Q2 2023$1,154,366
+14.5%
350,871
+10.7%
0.00%
Q1 2023$1,008,372
+156.3%
317,098
+457.8%
0.00%
Q4 2022$393,402
-36.9%
56,850
-42.2%
0.00%
Q3 2022$623,000
+148.2%
98,387
+62.6%
0.00%
Q2 2022$251,000
+54.9%
60,527
+81.0%
0.00%
Q1 2022$162,000
-71.8%
33,432
-42.0%
0.00%
Q4 2021$575,000
-74.3%
57,657
-50.8%
0.00%
Q3 2021$2,237,000
-64.4%
117,086
-40.4%
0.00%
-100.0%
Q2 2021$6,278,000
-19.0%
196,313
-23.6%
0.00%
-50.0%
Q1 2021$7,749,000
-37.8%
257,016
-10.7%
0.00%
-33.3%
Q4 2020$12,450,000
-12.3%
287,715
+9.4%
0.00%
-25.0%
Q3 2020$14,193,000
-6.0%
263,087
+6.4%
0.00%0.0%
Q2 2020$15,096,000
+45.4%
247,306
+9.5%
0.00%0.0%
Q1 2020$10,380,000
-37.7%
225,846
+19.0%
0.00%0.0%
Q4 2019$16,650,000
+26.6%
189,745
+32.5%
0.00%0.0%
Q3 2019$13,148,000
-27.3%
143,188
+0.6%
0.00%
-20.0%
Q2 2019$18,097,000
-11.8%
142,267
+9.1%
0.01%
-16.7%
Q1 2019$20,511,000
+121.1%
130,363
+39.4%
0.01%
+100.0%
Q4 2018$9,278,000
-9.4%
93,536
+33.4%
0.00%0.0%
Q3 2018$10,237,000
-3.1%
70,117
+4.2%
0.00%0.0%
Q2 2018$10,566,000
-25.8%
67,319
-19.3%
0.00%
-25.0%
Q1 2018$14,240,000
+3.3%
83,400
+7.7%
0.00%0.0%
Q4 2017$13,788,000
-60.5%
77,413
-69.6%
0.00%
-63.6%
Q3 2017$34,922,000
+12.1%
254,259
-14.2%
0.01%
+10.0%
Q2 2017$31,140,000
+0.7%
296,423
-12.8%
0.01%0.0%
Q1 2017$30,913,000
+7.0%
340,069
-27.3%
0.01%0.0%
Q4 2016$28,878,000
+0.1%
468,012
+10.0%
0.01%
-9.1%
Q3 2016$28,850,000
+51.2%
425,639
-3.4%
0.01%
+57.1%
Q2 2016$19,084,000
-0.3%
440,830
-2.1%
0.01%
-12.5%
Q1 2016$19,137,000
-37.2%
450,284
-5.2%
0.01%
-33.3%
Q4 2015$30,492,000
+15.2%
474,832
+53.4%
0.01%
+9.1%
Q3 2015$26,480,000
-38.3%
309,529
+17.7%
0.01%
-35.3%
Q2 2015$42,901,000
-51.6%
263,084
-64.1%
0.02%0.0%
Q1 2015$88,624,000
+159.0%
733,820
+96.7%
0.02%
+30.8%
Q4 2014$34,224,000
+23341.1%
373,118
+9115.1%
0.01%
Q3 2014$146,000
-30.1%
4,049
-25.1%
0.00%
Q2 2014$209,000
+72.7%
5,408
+1.2%
0.00%
Q1 2014$121,000
+4.3%
5,342
-3.6%
0.00%
Q4 2013$116,000
+427.3%
5,544
+588.7%
0.00%
Q3 2013$22,0008050.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders